Skip to content

Author

Si-Da Huang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Broad genomic profiling, targeted therapy receipt, and overall survival among patients with metastatic non-squamous non-small cell lung cancer.

51 Background: Broad genomic profiling (BGP) is recommended for all patients with metastatic non-squamous NSCLC to guide targeted therapy (TT) selection. As actionable alterations and matched therapies continue to expand, BGP may identify a broader group of patients eligible for TT and consequently improve pati...

Si-Da Huang, John Rothen, Jessica B. Long et al. · 0 citations
Open access Oct 2026

Cost implications of broad genomic profiling among Medicare patients with metastatic lung cancer.

37 Background: Broad genomic profiling (BGP) is increasingly used in metastatic non-small cell lung cancer (mNSCLC), but its association with downstream treatment-related Medicare spending compared to focused gene testing (FGT) remains unclear. Methods: We conducted a retrospective cohort study using SEER-Med...

Akintunde O. Aremu, Jessica B. Long, John Rothen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.